Global Point of Care Diagnostics Market
Point Of Care Diagnostics Market

Report ID: SQMIG35D2329

sales@skyquestt.com
USA +1 351-333-4748

Point Of Care Diagnostics Market Size, Share, and Growth Analysis

Global Point of Care Diagnostics Market

Point of Care Diagnostics Market Size, Share & Trends Analysis Report, By Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, Others), By Product, By End User, By Region, And Industry Forecast, 2026-2033


Report ID: SQMIG35D2329 | Region: Global | Published Date: July, 2025
Pages: 197 |Tables: 111 |Figures: 68

Format - word format excel data power point presentation

Point Of Care Diagnostics Market Insights

Global Point of Care Diagnostics Market size was valued at USD 47.4 Billion in 2024 and is poised to grow from USD 50.01 Billion in 2025 to USD 76.75 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026–2033).

Key Takeaways: Market Trends & Insights

  • North America dominated the Point Of Care Diagnostics market with a largest market share in 2025.
  • The U.S. Point Of Care Diagnostics market is expected to grow significantly over the forecast period.
  • By End User, the Clinics segment held the largest Point Of Care Diagnostics market share in 2024.
  • The Home segment held the highest growing market over the forecast period.
  • North America: Largest Market in 2025
  • Asia Pacific: Fastest Growing Market
  • 2025 Market Size: USD 50.01 Billion
  • 2026 Projected Market Size: USD 52.76 Billion
  • 2033 Projected Market Size: USD 76.75 Billion
  • CAGR (2026-2033): 5.5%

Surge in prevalence of infectious diseases, rising burden of chronic diseases around the world, adoption of home-based and decentralized care, availability of favorable policies, and emphasis on patient empowerment are boosting sales of point of care diagnostics solutions.

A consumer‑driven movement towards self‑care is primarily bolstering point of care diagnostics market growth. Governments and healthcare programs are promoting decentralized care models, further driving integration of point of care diagnostics into primary care and home settings. A robust increase in geriatric population base coupled with chronic disease incidence like diabetes, cardiovascular disorders, and cancer is driving demand for continuous, decentralized monitoring. POC diagnostics for glucose, lipids, cardiac markers, and biomarkers enable rapid, on‑site testing that supports proactive disease management. The global increase in infectious diseases like COVID‑19, HIV, tuberculosis, and malaria has significantly accelerated demand for rapid, on‑site diagnostic testing, thereby boosting popularity of point of care diagnostics.

On the contrary, high costs of advanced point of care devices, complexity in regulations and reimbursement policies, variability in accuracy, and limited technical expertise in developing regions are estimated to limit the global point of care diagnostics market penetration through 2032 and beyond.

How Digital Health Integration Transforming Point of Care Diagnostics?

The integration of point of care diagnostics with digital health technologies is revolutionizing patient monitoring and care delivery. Many modern point of care devices is now Bluetooth-enabled and compatible with smartphones or tablets, allowing real-time transmission of diagnostic data to healthcare providers. Integration with telemedicine platforms enhances remote patient management, especially for chronic illnesses and infectious diseases. AI-powered algorithms are also improving test interpretation and reducing human error. This digital synergy enhances personalized treatment plans, accelerates clinical decisions, and strengthens continuity of care. As healthcare increasingly shifts toward remote and value-based models, digital integration is becoming central point of care diagnostics in the future landscape.

Point Of Care Diagnostics Market Infographics

To get more insights on this market click here to Request a Free Sample Report

Point Of Care Diagnostics Market Segments Analysis

Global point of care diagnostics market is segmented by product, sample, end user, and region. Based on product, the market is segmented into glucose testing, Hb1Ac testing, coagulation testing, fertility/pregnancy, infectious disease, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug of abuse (DOA) testing, autoimmune diseases, urinalysis/nephrology. Based on samples, the market is segmented into blood, nasal and oropharyngeal swabs, urine, and other factors. Based on end user, the market is segmented into clinics (pharmacy & retail clinics, physician office, urgent care clinics, non-practice clinics), hospitals, homes, assisted living healthcare facilities, and laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Which Point of Care Diagnostics Product is Slated to Bring in the Most Revenue?

The infectious disease segment is estimated to hold the highest global point of care diagnostics market share going forward. The surge in demand for rapid testing of infectious diseases and emphasis on improving infectious disease management are helping this segment maintain a dominant stance. Government efforts to restrict the rising prevalence of multiple types of infectious diseases are also helping this segment hold sway over others.

On the other hand, the demand for cancer markets is expected to rise at a robust pace over the coming years as per this point of care diagnostics market forecast. Growing incidence of cancer around the world and growing emphasis on early detection of cancer are helping make this a highly opportune segment in the future.

Where are Most Point of Care diagnostics Solutions Used?

The clinics segment is slated to spearhead the global point of care diagnostics market revenue generation potential over the coming years. Professionals working in clinics are shifting towards point of care diagnostics from conventional lab testing to help shorten testing time and improve patient outcomes. Low costs and easy availability of point of care diagnostics tests are also helping boost their adoption in clinics.

Meanwhile, the demand for point of care diagnostics in the home segment is slated to rise at a notable pace over the coming years. Rising popularity of homecare around the world and increasing preference for the same by geriatric population are helping create new opportunities via this segment.

Global Point of Care Diagnostics Market By End User 2026-2033
Point Of Care Diagnostics Market Segments Analysis

To get detailed segments analysis, Request a Free Sample Report

Point Of Care Diagnostics Market Regional Insights

Why is Adoption of Point of Care Diagnostics High in North America?

The presence of an advanced healthcare infrastructure and high chronic disease prevalence are helping this region lead global point of care diagnostics demand. Early adoption of innovative point of care diagnostic technologies, government funding, and favorable reimbursement frameworks are also forecasted to help this region maintain its high share over the coming years. Consumer familiarity with self-testing devices and surge in popularity of home healthcare are also estimated to boost revenue generation potential of this region through 2032.

Point Of Care Diagnostics Market in United States

The surge in demand for rapid testing and presence of a well-developed healthcare infrastructure make this country the largest market for point of care diagnostics providers. Presence of top point of care diagnostics companies such as Abbott, BD, and Quidel also helps the United States hold sway over other countries. CLIA-waived tests enable decentralized diagnostics in clinics, pharmacies, and home settings. Adoption of telehealth and digital platforms is also estimated to create new opportunities in the long run.

Point of Care Diagnostics Market in Canada

A shift towards decentralized care and emphasis on improving healthcare access in rural areas are promoting point of care diagnostics adoption in Canada. Health Canada regulates and approves home-use and clinical POC tests with increasing efficiency Strong emphasis on patient-centric care is also anticipated to create new business scope for point of care diagnostics companies. Canada's point of care diagnostics market also benefits from collaborations with manufacturers from the United States and local innovation.

Why are Point of Care Diagnostics Innovators Targeting Asia Pacific?

Improving healthcare accessibility and growing prevalence of infectious and chronic diseases are helping make Asia Pacific the most opportune region for point of care diagnostics providers. Robust investments in rural healthcare infrastructure development and telemedicine adoption are also projected to boost point of care diagnostics demand in countries such as South Korea, China, Japan, Indonesia, and India going forward. The shift toward decentralized testing in resource-limited settings and rising demand for self-diagnostic tools are forecasted to ensure a sustained demand for novel point of care diagnostics solutions.

Point of Care Diagnostics Market in Japan

Growing incidence of lifestyle-related diseases such as diabetes and cardiovascular conditions coupled with a massive geriatric population make Japan a key market for point of care diagnostics providers. Demand for advanced molecular and immunoassay-based devices is high among the Japanese population. Domestic companies like Sysmex and Nipro are also playing a crucial role in driving innovation in point of care diagnostics. Cultural preference for preventive healthcare further boosts home and clinic-based POC testing.

Point of Care Diagnostics Market in South Korea

Launch of new government health initiatives and presence of a digitally savvy population are helping boost point of care diagnostics demand in South Korea. Strong national health insurance and proactive disease screening programs support diagnostic adoption. Integration of point of care diagnostics with mobile health and telemedicine platforms is expected to be a popular trend in the long run. South Korea’s innovation ecosystem facilitates collaboration between academia, industry, and government.

Should Point of Care Diagnostics Companies Invest in Europe?

The presence of strong public healthcare systems and growing emphasis on preventive healthcare are estimated to bolster the sales of point of care diagnostics solutions in Europe. Regulatory support and reimbursement for home-based diagnostics are also predicted to create new opportunities for point of care diagnostics companies in the long run. Cross-border collaborations and government funding are slated to play a crucial role in advancing the point of care diagnostics innovation over the coming years.

Point of Care Diagnostics Market in United Kingdom

NHS-led digital transformation and growing emphasis on chronic disease management are expected to govern point of care diagnostics demand in the United Kingdom. Incorporation of point of care testing into primary care for managing diabetes, infections, and cardiovascular risks is also helping expand revenue generation for market players. Strategic partnerships, academic collaborations, and government funding are further creating new business scope for market players operating in the country.

Point of Care Diagnostics Market in Germany

Presence of a developed healthcare infrastructure and government emphasis on preventive care are forecasted to make Germany a key market for point of care diagnostics providers. The senescent population of the country is driving up the demand for advanced and quick point of care diagnostics. Germany’s decentralized healthcare model favors adoption of rapid testing in pharmacies and general practices. The presence of leading diagnostics companies such as Roche and Siemens is also helping create new opportunities in the country.

Point of Care Diagnostics Market in France

Rising emphasis on early detection of diseases and improvement of outpatient care are helping boost point of care diagnostics adoption in the country. The Assurance Maladie national insurance system supports partial reimbursement for approved POC tests, improving accessibility. France’s investment in e-health infrastructure, combined with an increasing emphasis on patient autonomy and home-based care, strengthens the POC diagnostics ecosystem nationwide.

Global Point of Care Diagnostics Market By Region, 2026-2033
Point Of Care Diagnostics Market Regional Analysis

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Point Of Care Diagnostics Market Dynamics

Point of Care Diagnostics Market Drivers

Advancements in Point of Care Diagnostics Technologies

  • Advanced technologies such as microfluidics, lab‑on‑a‑chip platforms, biosensors, and AI have made point of care diagnostics solutions more compact and accurate. High‑performance multiplex assays enable simultaneous detection of multiple biomarkers from a single sample, enhancing efficiency. Such advancements help simplify workflows, reduce user error, and extend point of care diagnostics applicability across clinical and non‑clinical environments.

Availability of Favorable Policies and Funding

  • Rising efforts of governments and global health organizations to improve healthcare accessibility are driving investments in point of care diagnostics. CLIA waivers and approvals reduce regulatory barriers for simpler tests. Funding for decentralized healthcare infrastructure, especially in emerging economies, supports widespread deployment. Public‑private partnerships accelerate product development and clinical adoption, while reimbursement reforms incentivize adoption and support the overall point of care diagnostics market outlook.

Point of Care Diagnostics Market Restraints

Variability in Accuracy and Quality Assurance

  • Point of care testing experiences lower sensitivity and specificity than centralized laboratory assays, especially in environments with varying operator skills or ambient conditions. In rural or home settings, lack of calibration, standardized procedures, and trained personnel increases error risk. Maintaining consistent quality requires robust design, frequent validation, and oversight often lacking in decentralized deployments. These limitations diminish clinical trust and adoption of point of care diagnostics.

High Costs of Advanced Devices and Consumables

  • Advanced point of care diagnostics equipment and instruments such as molecular and multiplex analyzers are priced at a premium. Reagent costs, calibration, maintenance, and quality control further escalate total cost of ownership. Budget constraints in smaller practices, rural clinics, and low‑income countries amplify adoption barriers. These high costs of advanced point of care diagnostics solutions are expected to hamper the overall point of care diagnostics adoption in the long run.

Request Free Customization of this report to help us to meet your business objectives.

Point Of Care Diagnostics Market Competitive Landscape

Point of care diagnostics providers should focus on increasing the efficacy of their tests and reduce their result times by investing in R&D. Developing at-home and rapid POC test kits is also a prominent opportunity for companies as per this global point of care diagnostics market analysis. Targeting countries with developed healthcare infrastructure is also a key strategy for all market players.

Reducing the costs and results of novel point of care diagnostics is slated be the prime focus of new companies. Here’s a startup that has the potential to augment the point of care diagnostics industry in the long run.

  • Biosensorix: Based in Singapore, the startup is focused on the development of low-cost and effective point of care solutions. The 2015-founded startup has gained a reputation for its immune assay-based platform called ELLI that detects biomarkers and pathogens. The company also offers other solutions called StackPad, which is a laboratory-grade rapid and low-cost multiplex biomarker and pathogen detector, and BioPen, which uses fiber-optic biosensors for detection of DNA, RNA, antibodies.

Top Player’s Company Profiles

  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Chembio Diagnostics (US)
  • EKF Diagnostics (UK)
  • Trinity Biotech plc (Ireland)
  • Instrumentation Laboratory (US)
  • PTS Diagnostics (US)
  • Sekisui Diagnostics (US)

Recent Developments in Point of Care Diagnostics Market

  • In June 2025, Philips, a multinational health technology company launched a new point of care ultrasound system designed specifically for critical care environments. The cart-based Flash 5100 POC system includes artificial-intelligence-powered automation software as well as a large touch screen to ensure optimal usability.
  • In June 2025, Brina Medical LLC, a company focused on redifning diagnostic precision announced the launch of a novel next-generation point-of-care diagnostic device. CMAT Advantage is a device engineered to empower hospitals and healthcare providers to outpace the rapid surge in chronic disease incidence.
  • In April 2025, Diagnostics for the Real World (DRW), a leading provider of innovative point of care diagnostics, announced that it was preparing for the launch of its new retooled point of care diagnostics platform. The company also revealed plans to launch six new test panels along with its novel platform.

Point Of Care Diagnostics Key Market Trends

Point Of Care Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, the growing prevalence of chronic diseases and advancements in point of care diagnostics technologies are anticipated to drive the demand for point of care diagnostics going forward. However, high costs of devices and variability in accuracy are slated to slow down the adoption of point of care diagnostics in the future. North America is slated to spearhead the demand for point of care diagnostics owing to the presence of a developed healthcare infrastructure and favorable reimbursement policies. The development of at-home testing kits and expansion of molecular POC testing are anticipated to be key trends driving the point of care diagnostics industry through 2032 and beyond.

Report Metric Details
Market size value in 2024 USD 47.4 Billion
Market size value in 2033 USD 76.75 Billion
Growth Rate 5.5%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology
  • Sample
    • Blood, Nasal and Oropharyngeal Swabs, Urine, Others
  • End User
    • Clinics (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Chembio Diagnostics (US)
  • EKF Diagnostics (UK)
  • Trinity Biotech plc (Ireland)
  • Instrumentation Laboratory (US)
  • PTS Diagnostics (US)
  • Sekisui Diagnostics (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Point Of Care Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Point Of Care Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Point Of Care Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Point Of Care Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Point Of Care Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Point Of Care Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

Point Of Care Diagnostics Market Report Snapshots

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Point of Care Diagnostics Market size was valued at USD 47.4 Billion in 2024 and is poised to grow from USD 50.01 Billion in 2025 to USD 76.75 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026–2033).

Point of care diagnostics providers should focus on increasing the efficacy of their tests and reduce their result times by investing in R&D. Developing at-home and rapid POC test kits is also a prominent opportunity for companies as per this global point of care diagnostics market analysis. Targeting countries with developed healthcare infrastructure is also a key strategy for all market players. 'Abbott Laboratories (US)', 'Siemens Healthineers AG (Germany)', 'Quidel Corporation (US)', 'F. Hoffman-La Roche Ltd. (Switzerland)', 'Danaher Corporation (US)', 'Becton, Dickinson and Company (US)', 'Chembio Diagnostics (US)', 'EKF Diagnostics (UK)', 'Trinity Biotech plc (Ireland)', 'Instrumentation Laboratory (US)', 'PTS Diagnostics (US)', 'Sekisui Diagnostics (US)'

Advanced technologies such as microfluidics, lab‑on‑a‑chip platforms, biosensors, and AI have made point of care diagnostics solutions more compact and accurate. High‑performance multiplex assays enable simultaneous detection of multiple biomarkers from a single sample, enhancing efficiency. Such advancements help simplify workflows, reduce user error, and extend point of care diagnostics applicability across clinical and non‑clinical environments.

Expansion of Molecular POC Testing: Advancements in molecular diagnostics technologies have brought them out of the confines of laboratories to point of care settings. Rapid molecular assays for infectious diseases such as COVID-19, influenza, and STDs offer high accuracy and fast turnaround times, improving outbreak containment and targeted treatment. Platforms using isothermal amplification or CRISPR-based detection are gaining traction due to their simplicity and portability. The growing demand for quick, accurate diagnostics is expected to make this an indispensable point of the care diagnostics industry trend in the long run.

Why is Adoption of Point of Care Diagnostics High in North America?
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients